6-dodecyl-2-methoxy-1,4-benzoquinone has been researched along with Cancer of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, W; Chen, C; Chen, X; Gao, Y; He, J; Huang, R; Nong, Z; Tang, X; Xie, Q | 1 |
Almosnid, NM; Altman, E; Chippada-Venkata, UD; Farone, A; Gao, Y; Gong, Y; Hosain, NA; Huang, R; Park, HS; Vick, E; Wen, Q | 1 |
2 other study(ies) available for 6-dodecyl-2-methoxy-1,4-benzoquinone and Cancer of Lung
Article | Year |
---|---|
2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione inhibits the growth and metastasis of breast carcinoma in mice.
Topics: Animals; Apoptosis; Body Weight; Cell Line, Tumor; Cell Proliferation; Cyclohexenes; Cytokines; Female; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Animal; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred BALB C; NF-kappa B; Phosphorylation; Survival Analysis; Xenograft Model Antitumor Assays | 2017 |
The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Averrhoa; Bone Neoplasms; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclohexenes; Cytochromes c; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypoglycemic Agents; Inhibitory Concentration 50; Lung Neoplasms; MCF-7 Cells; NF-kappa B; Oxidative Stress; Phosphorylation; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2015 |